| Literature DB >> 29622075 |
Ahmed H El-Sherief1, Charles T Lau2, Brett W Carter3, Carol C Wu3.
Abstract
This article reviews regional lymph node assessment in lung cancer. In the absence of a distant metastasis, the absence or location of lung cancer spread to a regional mediastinal lymph node affects treatment options and prognosis. Regional lymph node maps have been created to standardize assessment of the N descriptor. The International Association for the Study of Lung Cancer lymph node map is used for the standardization of N descriptor assessment. CT, PET/CT with fluorodeoxyglucose, endobronchial ultrasound-guided and/or esophageal ultrasound-guided biopsy, and mediastinoscopy are common modalities used to determine the N descriptor. Published by Elsevier Inc.Entities:
Keywords: International association for the study of lung cancer (IASLC); Lung cancer; Lymph node; Lymph node map; Staging
Mesh:
Year: 2018 PMID: 29622075 DOI: 10.1016/j.rcl.2018.01.008
Source DB: PubMed Journal: Radiol Clin North Am ISSN: 0033-8389 Impact factor: 2.303